EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA

Immunotherapy has revolutionized the treatment of many tumors. However, most glioblastoma (GBM) patients have not, so far, benefited from such successes. With the goal of exploring ways to boost anti-GBM immunity, we developed a B-cell-based vaccine (B(Vax)) that consists of 4-1BBL(+) B cells activa...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Lee Chang, Catalina, Miska, Jason, Hou, David, Rashidi, Aida, Zhang, Peng, Burga, Rachel, Torres, Ignacio Jusue, Xiao, Ting, Arrieta, Victor, Zhang, Daniel, Lopez-Rosas, Aurora, Han, Yu, Sonabend, Adam, Horbinski, Craig, Stupp, Roger, Balyasnikova, Irina, Lesniak, Maciej
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Preclinical Experimental Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651425/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.397
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items